GT Biopharma (OXIS) is now something that a lot of you have become familiar with. The latest announcement from (OXIS) is centered around the upcoming conference call, which BiotechStocks.com will be hosting. Keep in mind that not only does this come after the recent surge in trading but also following the company’s most recent announcements. These include the addition of new patients to the company’s Phase 2 FDA trials as well as the previously announced agreement to acquire Georgetown Translational Pharmaceuticals Inc.
Knowing what we know now about the proposed acquisition, this could be a vital next step for all who are following (OXIS). The company will be hosting a conference call to go into the details of its latest developments at 4:15pm EST on Wednesday, August 16, 2017. The dial in number for the call is 712-775-7031. Meeting ID number is 576-591-822.